ArticleThe oncologist2025

Phase Ib study of berzosertib, carboplatin, gemcitabine, and pembrolizumab in patients with squamous nonsmall lung cancer (ETCTN 10313).

Liza C Villaruz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.